Accumulating evidence indicates that nitric oxide (NO) inhibits the function of monoamine
transporters. Because the production of NO by neuronal NO synthase (nNOS) is closely …

Neurochemical and morphological evidence has shown that some neurotransmitters or
substances may be released from both synaptic and nonsynaptic sites for diffusion to target …

Attention deficit hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental
disorder of childhood. It is primarily characterised by high levels of activity, inattention, and …

Superfused synaptosomes have been utilized in studies of neurotransmitter release during
25 years. This review summarizes the aspects of neurotransmission that have been and …

Data accumulated in the last decade indicate that nitric oxide (NO) participates in the
regulation of neurotransmission in the central nervous system. Due to its physicochemical …

The dominant research subject on schizophrenia, mood disorders, autism and other central
nervous system diseases has been related to neurotransmitter system abnormalities. For …

Exposure to galactic cosmic radiation (GCR) is considered to be a potential health risk in
long-term space travel, and it represents a significant risk to the central nervous system …

Background Major depressive disorder is a leading cause of disability worldwide, affecting
up to 17% of the general population. The neural mechanisms of depression, however, are …

Nitric oxide (NO) has been established as an important messenger molecule in various
steps of brain physiology, from development to synaptic plasticity, learning and memory …

Mood disorders are chronic, recurrent mental diseases that affect millions of individuals
worldwide. Although over the past 40 years the biogenic amine models have provided …